U S PHYSICAL THERAPY INC /NV Income (Loss) from Equity Method Investments
U S PHYSICAL THERAPY INC /NV (USPH) reported Income (Loss) from Equity Method Investments of $408.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for the quarter ending 2026-06-30 was $408.00K, a 1.75% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for the quarter ending 2026-03-31 was $363.00K, a 7.63% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for the quarter ending 2025-12-31 was $322.00K, a 21.97% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for the quarter ending 2025-09-30 was $361.00K, a 56.28% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for fiscal 2025 was $1.48M, a 45.66% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for fiscal 2024 was $1.01M, a 6.18% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for fiscal 2023 was $955.00K, a 18.72% decline from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV income (loss) from equity method investments for fiscal 2022 was $1.18M, a 949.11% increase from fiscal 2021.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $408.00K 10-Q · filed 2026-08-07 | $772.00K 10-Q · filed 2026-08-07 | $1.09M derived: sum of 3 quarters · filed 2026-08-07 | $1.45M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $363.00K 10-Q · filed 2026-05-08 | $685.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.05M derived: sum of 3 quarters · filed 2026-05-08 | $1.45M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $683.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.08M derived: sum of 3 quarters · filed 2026-08-07 | $1.48M 10-K · filed 2026-02-27 |
| 2025-09-30 | $361.00K 10-Q · filed 2025-11-07 | $762.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.16M 10-Q · filed 2025-11-07 | $1.42M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $401.00K 10-Q · filed 2026-08-07 | $794.00K 10-Q · filed 2026-08-07 | $1.06M derived: sum of 3 quarters · filed 2026-08-07 | $1.29M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $393.00K 10-Q · filed 2026-05-08 | $657.00K derived: sum of 2 quarters · filed 2026-05-08 | $888.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.14M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $495.00K derived: sum of 2 quarters · filed 2026-02-27 | $743.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.01M 10-K · filed 2026-02-27 |
| 2024-09-30 | $231.00K 10-Q · filed 2025-11-07 | $479.00K derived: sum of 2 quarters · filed 2025-11-07 | $750.00K 10-Q · filed 2025-11-07 | $899.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $248.00K 10-Q · filed 2025-08-08 | $519.00K 10-Q · filed 2025-08-08 | $668.00K derived: sum of 3 quarters · filed 2026-02-27 | $874.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $271.00K 10-Q · filed 2025-05-09 | $420.00K derived: sum of 2 quarters · filed 2026-02-27 | $626.00K derived: sum of 3 quarters · filed 2026-02-27 | $952.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $355.00K derived: sum of 2 quarters · filed 2026-02-27 | $681.00K derived: sum of 3 quarters · filed 2026-02-27 | $955.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $206.00K 10-Q · filed 2024-11-08 | $532.00K derived: sum of 2 quarters · filed 2024-11-08 | $806.00K 10-Q · filed 2024-11-08 | $998.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $326.00K 10-Q · filed 2024-08-14 | $600.00K 10-Q · filed 2024-08-14 | $792.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $274.00K 10-Q · filed 2024-05-08 | $466.00K derived: sum of 2 quarters · filed 2025-03-03 | $770.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.11M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $496.00K derived: sum of 2 quarters · filed 2025-03-03 | $836.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.18M 10-K · filed 2025-03-03 |
| 2022-09-30 | $304.00K 10-Q · filed 2023-11-08 | $644.00K derived: sum of 2 quarters · filed 2023-11-08 | $983.00K 10-Q · filed 2023-11-08 | $1.09M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $340.00K 10-Q · filed 2023-08-09 | $679.00K 10-Q · filed 2023-08-09 | $791.00K derived: sum of 3 quarters · filed 2024-02-29 | $791.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $339.00K 10-Q · filed 2023-05-05 | $451.00K derived: sum of 2 quarters · filed 2024-02-29 | $451.00K derived: sum of 3 quarters · filed 2024-02-29 | $451.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $112.00K derived: sum of 2 quarters · filed 2024-02-29 | $112.00K derived: sum of 3 quarters · filed 2024-02-29 | $112.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |